Nishikawa S
Third Department of Internal Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Hokkaido Igaku Zasshi. 1989 Jul;64(4):440-9.
Aldolase A, B, and C were determined in rat liver and serum by radioimmunoassay (RIA) in order to evaluate the alteration of these isozymes in the process of hepatocarcinogenesis induced by 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB), and the immunohistochemical technique was also used for the analysis of localization of aldolase isozymes. Aldolase A was increased in cancer tissues of 3'-Me-DAB induced hepatoma, whereas aldolase B was decreased in the same tissues according to both RIA and the immunohistochemical technique. During the promotion stage of hepatocarcinogenesis, the cells in hyperplastic nodules, which are known as preneoplastic lesions, were stained for aldolase A. Aldolase C was slightly increased in cancer tissues by RIA, suggesting the increase of A-C hybrid like A3C which was demonstrated by the electrophoretic method. Serum aldolase A levels were not significantly elevated in rats with liver cancer in comparison to rats with non-cancer.
采用放射免疫分析法(RIA)测定大鼠肝脏和血清中的醛缩酶A、B和C,以评估3'-甲基-4-二甲基氨基偶氮苯(3'-Me-DAB)诱导肝癌发生过程中这些同工酶的变化,同时采用免疫组织化学技术分析醛缩酶同工酶的定位。根据RIA和免疫组织化学技术,3'-Me-DAB诱导的肝癌癌组织中醛缩酶A增加,而同一组织中的醛缩酶B减少。在肝癌发生的促进阶段,增生性结节(即癌前病变)中的细胞被醛缩酶A染色。通过RIA检测发现癌组织中醛缩酶C略有增加,提示电泳法所证实的A-C杂交体如A3C增加。与非癌大鼠相比,肝癌大鼠血清醛缩酶A水平无显著升高。